What is it?
Lycopene, found primarily in tomatoes, is a member of the carotenoid family—which includes beta-carotene and similar compounds found naturally in
food—and has potent antioxidant
capabilities.
A study conducted by Harvard researchers examined the relationship between carotenoids and
the risk of prostate cancer.1 Of
the carotenoids studied, only lycopene was clearly linked to protection. The men who had the
greatest amounts of lycopene in their diet (6.5 mg per day or more) showed a 21% decreased
risk of prostate cancer compared with those
eating the least. This report suggests that lycopene may be an important tool in the
prevention of prostate cancer. This study also reported that those who ate more than ten
servings per week of tomato-based foods had a 35% decreased risk of prostate cancer compared
with those eating less than 1.5 weekly servings. When the researchers looked at only advanced
prostate cancer, the high lycopene eaters had an 86% decreased risk (although this did not
reach statistical significance due to the small number of cases).
Contrary to popular opinion, research suggests that there is no preferential concentration
of lycopene in prostate tissue.2 Although prostate cancer patients have been
reported to have low levels of lycopene in the blood,3 and lycopene appears to be a
potent inhibitor of human cancer cells in
test-tubes,4 evidence is conflicting concerning whether an increased intake of
tomato products is protective against prostate cancer. Some studies, like the one discussed
above, have reported that high consumption of tomatoes and tomato products reduces risk of
prostate cancer.5 6 Other studies, however, are
inconclusive,7 and some have found no protective association.8
9 10 11 12
There is some evidence that lycopene may be helpful in the treatment of prostate cancer. In
a preliminary trial, 26 men with prostate cancer were randomly assigned to receive lycopene
(15 mg twice a day) or no lycopene for three weeks before undergoing prostate surgery.
Prostate tissue was then obtained during surgery and examined. Compared with the
unsupplemented men, those receiving lycopene were found to have significantly less aggressive
growth of cancer cells.13 In addition, a case report has been published of a
62-year-old man with advanced prostate cancer who experienced a regression of his tumour after
starting 10 mg of lycopene per day and 300 mg of
saw palmetto three times per day. As saw palmetto has not been previously associated with
improvements in prostate cancer, the authors of the report attributed the response to the
lycopene.14 Long-term controlled studies are needed to confirm these promising
initial reports.
There is no evidence that tomato intake has any effect on benign prostatic hyperplasia (BPH).
Another study found that for the 25% of people with the greatest tomato intake, the risk
for cancers of the gastrointestinal tract was 30–60% lower, compared with those who ate
fewer tomatoes. These reduced risks were statistically significant.15 A study of
women found that the 75% who ate the least amount of tomatoes had between 3.5 and 4.7 times
the risk for pre-cancerous changes of the cervix (cervical intraepithelial
neoplasia).16 Other researchers have also reported evidence suggesting that high
dietary lycopene may be linked to protection from
cervical dysplasia.17 While preliminary evidence also links dietary lycopene
with protection from breast
cancer,18 another study did not find this link.19
In a review of 72 studies,20 one researcher reported 57 associations between
tomato intake or blood lycopene levels and decreased risk of cancer. Of these associations, 35
were statistically significant. The benefit was strongest for prostate, lung, and stomach cancers, although protective
associations were also found for cancers of the pancreas, colon, rectum, oesophagus, oral cavity, breast, and
cervix. Because the data were from observational studies, a cause-and-effect relationship
cannot be firmly established. However, the consistently lower risk of cancer associated with
higher consumption of lycopene-containing tomatoes, provides a strong foundation for further
research on lycopene.
In Europe, researchers have found a statistically significant association between high
dietary lycopene and a 48% lower risk of heart
disease.21 Lycopene supplementation has also boosted immune function in the elderly. In that trial, 15 mg
of lycopene per day increased natural killer cell activity by 28% in 12
weeks.22
1. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and
retinol in relation to risk of prostate cancer. J Natl Cancer Inst
1995;87:1767–76.
2. Kristal AR, Cohen JH. Invited commentary: tomatoes, lycopene, and
prostate cancer. How strong is the evidence? Am J Epidemiol 2000;151:124–7
[review, discussion 128–30].
3. Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and
biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr
Cancer 1999;33:159–64.
4. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent
inhibitory of human cancer cell proliferation than either alpha-carotene or beta-carotene.
Nutr Cancer 1995;24:257–66.
5. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet,
lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598–604.
6. Tzonou A, Signorello LB, Lagiou P, et al. Diet and cancer of the
prostate: a case-control study in Greece. Int J Cancer 1999;80:704–8.
7. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and
dietary carotenoids. Am J Epidemiol 2000;151:119–23.
8. Deneo H-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M. Foods,
nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer
1999;80:591–7.
9. Schuman L, Mandel J, Radke A. Some selected features of the
epidemiology of prostate cancer: Minneapolis-St. Paul, Minnesota case-control study,
1976–1979. In: Magnus K (ed). Trends in cancer incidence: causes and
implications. Washington, DC: Hemisphere Publishing Corporation, 1982, 345–54.
10. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet
and prostate cancer. Br J Cancer 1997;76:678–87.
11. Schuurman AG, Goldbohm RA, Dorant E, et al. Vegetable and fruit
consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol
Biomarkers Prev 1998;7:673–80.
12. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of
long-term supplementation with beta carotene on the incidence of malignant neoplasms and
cardiovascular disease. N Engl J Med 1996;334:1145–9.
13. Kucuk O, Sarkar FH, Sakr W, et al. Phase II randomized clinical trial
of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers
Prev 2001;10:861–8.
14. Matlaga BR, Hall MC, Stindt D, Torti FM. Response of hormone
refractory prostate cancer to lycopene. J Urol 2001;166:613.
15. Franceshci S, Bidoli E, La Vecchia C, et al. Tomatoes and risk of
digestive-tract cancers. Int J Cancer 1994;59:181–4.
16. Van Eenwyk J, Davis FG, Bowne PE. Dietary and serum carotenoids and
cervical intraepithelial neoplasia. Int J Cancer 1991;48:34–8.
17. Kanetsky PA, Gammon MD, Mandelblatt J, et al. Dietary intake and
blood levels of lycopene: association with cervical dysplasia among non-hispanic, black women.
Nutr Cancer 1998;31:31–40.
18. Dorgan JF, Sowell A, Swanson CA, et al. Relationships of serum
carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a
prospective study in Columbia, Missouri. Cancer Causes Control
1998;9:89–97.
19. Jarvinen R, Knekt P, Seppanen R, Teppo L. Diet and breast cancer in a
cohort of Finnish women. Cancer Lett 1997;114:251–3.
20. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer:
review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317–31.
21. Kohlmeyer L, Kark JD, Gomez-Gracia E, et al. Lycopene and myocardial
infarction risk in the EUROMIC study. Am J Epidemiol 1997;146:618–26.
22. Corridan BM, O’Donohue MP, Morrissey PA. Carotenoids and immune
response in elderly people. Proc Nutr Soc 1998;57:3A [abstr].
23. Paetau I, Rao D, Wiley ER, et al. Carotenoids in human buccal mucosa
cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am J Clin
Nutr 1999;70:490–4.
24. Paetau I, Khachik F, Brown ED, et al. Chronic ingestion of
lycopene-rich tomato juice or lycopene supplements significantly increases plasma
concentrations of lycopene and related tomato carotenoids in humans. Am J Clin Nutr
1998;68:1187–95.